Europe Situation Forecasts Change - Report Highlights Jazz Pharmaceuticals, Inc. and JA Solar Holdings Co., Ltd. (ADR)
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 11/10/11 -- Today, announced new reports highlighting Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) and JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO). Gain market insight with full analysis and research downloads available at .
With the European Financial Stability Facility set to increase to $1.4 trillion, it marks a significant move forward to strengthen the safety net in place for Europe's most troubled countries. Private bondholders of Greek debt are settling at a 50% haircut as another $180 billion in fresh aid is set to arrive, enabling banks to recapitalize at a healthy 9% reserve. Overall, these measures will bring Greece's debt burden down to 120% of GDP by 2020. An important consideration is political commitment to this road map. Currently the global community appears to be on point with ECB's initiative, an outlook that should be sufficient to support markets around current levels.
Brighton Markets is releasing new coverage on Jazz Pharmaceuticals, Inc. for its current position within the healthcare industry. Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the identification, development and commercialization of pharmaceutical products. The full research report on Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) is available here: .
Brighton Markets has released research on JA Solar Holdings Co., Ltd. (ADR) for its changing role within the technology industry. JA Solar Holdings Co., Ltd. (JA Solar) is a manufacturer of high-performance solar cells based in People's Republic of China. The Company produces and sells both monocrystalline and multicrystalline solar cells. The Company conducts its business primarily through its wholly owned subsidiaries in People's Republic of China, which includes JingAo Solar Co., Ltd. The full research report on JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) is available here: .
About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.
Contact:
Jean Barnes
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 10.11.2011 - 08:00 Uhr
Sprache: Deutsch
News-ID 1055781
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
NEW YORK, NY
Phone:
Kategorie:
Investment Services & Trading
Anmerkungen:
Diese Pressemitteilung wurde bisher 83 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Europe Situation Forecasts Change - Report Highlights Jazz Pharmaceuticals, Inc. and JA Solar Holdings Co., Ltd. (ADR)
"
steht unter der journalistisch-redaktionellen Verantwortung von
Brighton Markets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
